prescriberjournal.wordpress.com
Prescriber Forum | www.prescriber.co.ukwww.prescriber.co.uk
http://prescriberjournal.wordpress.com/
www.prescriber.co.uk
http://prescriberjournal.wordpress.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
1 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
5
SSL
EXTERNAL LINKS
1
SITE IP
192.0.78.13
LOAD TIME
1 sec
SCORE
6.2
Prescriber Forum | www.prescriber.co.uk | prescriberjournal.wordpress.com Reviews
https://prescriberjournal.wordpress.com
www.prescriber.co.uk
prescriberjournal.wordpress.com
Introduction of biosimilars: not to be confused with generics | Prescriber Forum
https://prescriberjournal.wordpress.com/2013/09/23/introduction-of-biosimilars-not-to-be-confused-with-generics
Introduction of biosimilars: not to be confused with generics. MSc, MPhil, DIC, DUniv, FRPharmS. Generic versions of branded medicines have been with us for a long time there was a proliferation of generic versions of aspirin, for example, when Bayer’s patent expired in 1917. So when is a generic not a generic? A generic isn’t a generic when it’s a biological drug. Biological drugs (biologics) are, generally, large molecules based on sugars, proteins, nucleic acids or complex combinations of these su...
prescriberjournal | Prescriber Forum
https://prescriberjournal.wordpress.com/author/prescriberjournal
Affording expensive new drugs. BMedSci, MRCGP, DRCOG, DipTher, DPH. Often lost in the indignant protests over the NHS not funding the latest ‘wonder drug’ is that such drugs can be eye-wateringly expensive. The latest furore has been over NICE’s provisional determination on Kadcyla (trastuzumab emtansine) the view from NICE was that this drug is not cost-effective unless the drug company reduces the price, which they have so far declined to do. The incremental cost-effectiveness ratio was estimated in th...
NICE CG178 on psychosis – an evidence-based guideline? | Prescriber Forum
https://prescriberjournal.wordpress.com/2014/04/24/nice-cg178-on-psychosis-an-evidence-based-guideline
NICE CG178 on psychosis an evidence-based guideline? MB BS and Mark Taylor. BSc, MD, FRCPsych, FRANZCP. In this editorial we summarise and critique NICE clinical guideline on. Psychosis and Schizophrenia in Adults: Treatment and Management. CBT as a panacea? And thus may not have capacity to consent to their treatment. Failure to offer the most evidence-based treatments promptly could be viewed as breaching the duty of care by the practitioner. It is also interesting that NICE seems to have ignored p...
Polypharmacy – essential, but also to be avoided | Prescriber Forum
https://prescriberjournal.wordpress.com/2014/02/06/polypharmacy-essential-but-also-to-be-avoided
Polypharmacy essential, but also to be avoided. BMedSci, MRCGP, DRCOG, DipTher, DPH. Polypharmacy is not new it was first described and discussed in the medical literature at least 150 years ago. Despite this, other than the dictionary definition of prescribing more than one drug at the same time to an individual, it is has been poorly characterised and under-researched. Problematic polypharmacy is defined as the prescribing of multiple medications inappropriately, or where the intended benefit of the me...
Affording expensive new drugs | Prescriber Forum
https://prescriberjournal.wordpress.com/2014/06/06/affording-expensive-new-drugs
Affording expensive new drugs. BMedSci, MRCGP, DRCOG, DipTher, DPH. Often lost in the indignant protests over the NHS not funding the latest ‘wonder drug’ is that such drugs can be eye-wateringly expensive. The latest furore has been over NICE’s provisional determination on Kadcyla (trastuzumab emtansine) the view from NICE was that this drug is not cost-effective unless the drug company reduces the price, which they have so far declined to do. The incremental cost-effectiveness ratio was estimated in th...
TOTAL PAGES IN THIS WEBSITE
5
Welcome to Prescriber Access
Prescriber Access Dashboard Info. Welcome to Prescriber Access. Please click the campaign button above to log in to your account.
prescriberdata.com
The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).
Pain Management Resources | Prescribe Responsibly
AAPM State Legislation and Regulation Tracking. The American Academy of Pain Management and Janssen Pharmaceuticals, Inc., worked together to conduct Community Connect. Events across the United States in 2014. The events focused on improving and fostering greater collaboration between pharmacists and prescribers caring for persons with pain. Content and Case studies. Clinical Opiate Withdrawal Scale. This site is published by Janssen Pharmaceuticals, Inc., which is solely responsible for its content.
Home
Access Pharmaceutical Pipeline Tracker. Pharmaceutical Pipeline Tracker Demo. Single Drug Report Sample. Drug Class Search Sample. Therapeutic Area Search Sample. Access Pharmaceutical Pipeline Tracker. Pharmaceutical Pipeline Tracker Demo. Single Drug Report Sample. Drug Class Search Sample. Therapeutic Area Search Sample. Pharmaceutical Pipeline Tracker.
prescriberinfo.com
The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).
prescriberjournal.wordpress.com
Prescriber Forum | www.prescriber.co.uk
Affording expensive new drugs. BMedSci, MRCGP, DRCOG, DipTher, DPH. Often lost in the indignant protests over the NHS not funding the latest ‘wonder drug’ is that such drugs can be eye-wateringly expensive. The latest furore has been over NICE’s provisional determination on Kadcyla (trastuzumab emtansine) the view from NICE was that this drug is not cost-effective unless the drug company reduces the price, which they have so far declined to do. The incremental cost-effectiveness ratio was estimated in th...
www.prescribersat.com
PrescribersConnection
The Nation's only LTC focused ePrescribing Network built to save you time and money! LTC ePrescribing Network and Services focused on excellence across the continuum of care. The ePrescribing Solution for Facilities and LTC Prescribers. PrescribersOrders is the complete system for Facilities to send ePrescriptions to as well as share patient information with their Long Term Care Pharmacy. PrescribersConnection LTC Network is the premier Long Term Care Network. ADL Data Systems, Inc. American Data, Inc.
www.prescribersletter.mobi
This Web page parked FREE courtesy of Domains Made Easy. Search for domains similar to. Is this your domain? Let's turn it into a website! Would you like to buy this. Find Your Own Domain Name. See our full line of products. Easily Build Your Professional Website. As low as $4.99/mo. Call us any time day or night .
prescribersletter.therapeuticresearch.com
Prescriber's Letter: Unbiased Recommendations You Can Trust on New Developments in Drug Therapy
Aug 13, 2015. You are eligible for:. Point of Care CME credits. Claim your credits now. Unbiased Recommendations You Can Trust on New Developments in Drug Therapy. PL VOICES Clinical Webinar Series. PL Rumor vs. Truth. Tell Jeff a Topic Idea. You may be interested in some of our other websites:. You’ll see LESS use of bridging with low-molecular-weight heparin (enoxaparin, etc) in warfarin patients. Table of Contents of Current Issue. View your CME history. List of New Drugs. Rumor vs. Truth.
